Munns CF - Search Results

1

Effect of Burosumab Compared With Conventional Therapy on Younger vs Older Children With X-linked Hypophosphatemia.

Ward LM, Glorieux FH, Whyte MP, Munns CF, Portale AA, Högler W, Simmons JH, Gottesman GS, Padidela R, Namba N, Cheong HI, Nilsson O, Mao M, Chen A, Skrinar A, Roberts MS, Imel EA. Ward LM, et al. Among authors: munns cf. J Clin Endocrinol Metab. 2022 Jul 14;107(8):e3241-e3253. doi: 10.1210/clinem/dgac296. J Clin Endocrinol Metab. 2022. PMID: 35533340 Free PMC article. Clinical Trial.

2

Effect of pamidronate treatment in children with polyostotic fibrous dysplasia of bone.

Plotkin H, Rauch F, Zeitlin L, Munns C, Travers R, Glorieux FH. Plotkin H, et al. J Clin Endocrinol Metab. 2003 Oct;88(10):4569-75. doi: 10.1210/jc.2003-030050. J Clin Endocrinol Metab. 2003. PMID: 14557424

3

Sclerotic metaphyseal lines in a child treated with pamidronate: histomorphometric analysis.

Rauch F, Travers R, Munns C, Glorieux FH. Rauch F, et al. J Bone Miner Res. 2004 Jul;19(7):1191-3. doi: 10.1359/JBMR.040303. Epub 2004 Jul 1. J Bone Miner Res. 2004. PMID: 15177003 Free article. No abstract available.

4

Respiratory distress with pamidronate treatment in infants with severe osteogenesis imperfecta.

Munns CF, Rauch F, Mier RJ, Glorieux FH. Munns CF, et al. Bone. 2004 Jul;35(1):231-4. doi: 10.1016/j.bone.2004.03.008. Bone. 2004. PMID: 15207762

5

The effect of cyclical intravenous pamidronate in children and adolescents with osteogenesis imperfecta type V.

Zeitlin L, Rauch F, Travers R, Munns C, Glorieux FH. Zeitlin L, et al. Bone. 2006 Jan;38(1):13-20. doi: 10.1016/j.bone.2005.07.020. Epub 2005 Sep 12. Bone. 2006. PMID: 16162424

6

Pamidronate in children and adolescents with osteogenesis imperfecta: effect of treatment discontinuation.

Rauch F, Munns C, Land C, Glorieux FH. Rauch F, et al. J Clin Endocrinol Metab. 2006 Apr;91(4):1268-74. doi: 10.1210/jc.2005-2413. Epub 2006 Jan 24. J Clin Endocrinol Metab. 2006. PMID: 16434452 Clinical Trial.

7

Vertebral morphometry in children and adolescents with osteogenesis imperfecta: effect of intravenous pamidronate treatment.

Land C, Rauch F, Munns CF, Sahebjam S, Glorieux FH. Land C, et al. Among authors: munns cf. Bone. 2006 Oct;39(4):901-6. doi: 10.1016/j.bone.2006.04.004. Epub 2006 May 26. Bone. 2006. PMID: 16730480

8

Acute phase response and mineral status following low dose intravenous zoledronic acid in children.

Munns CF, Rajab MH, Hong J, Briody J, Högler W, McQuade M, Little DG, Cowell CT. Munns CF, et al. Bone. 2007 Sep;41(3):366-70. doi: 10.1016/j.bone.2007.05.002. Epub 2007 May 13. Bone. 2007. PMID: 17574945 Clinical Trial.

9

Risedronate in the treatment of mild pediatric osteogenesis imperfecta: a randomized placebo-controlled study.

Rauch F, Munns CF, Land C, Cheung M, Glorieux FH. Rauch F, et al. Among authors: munns cf. J Bone Miner Res. 2009 Jul;24(7):1282-9. doi: 10.1359/jbmr.090213. J Bone Miner Res. 2009. PMID: 19257821 Free article. Clinical Trial.

10

Incidence of vitamin D deficiency rickets among Australian children: an Australian Paediatric Surveillance Unit study.

Munns CF, Simm PJ, Rodda CP, Garnett SP, Zacharin MR, Ward LM, Geddes J, Cherian S, Zurynski Y, Cowell CT; APSU Vitamin D Study Group. Munns CF, et al. Med J Aust. 2012 Apr 16;196(7):466-8. doi: 10.5694/mja11.10662. Med J Aust. 2012. PMID: 22509879

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

157 results

Search Page